Cold Chain Products Market: Growth, Size, Share, and Trends

Market Growth Outlook Summary

The global cold chain products market growth forecasted to transform from USD 569 million in 2022 to USD 711 million by 2027, driven by a CAGR of 4.5%. The market for cold chain products is expanding because of factors like rising zoonotic disease concerns, Rising use of immunoglobulins and other plasma products in a range of therapeutic area and Increasing demand for Plasma-derived medicinal products. The cold chain products industry is anticipated to develop because of the rising demand for plasma freezers and other cold chain products and the technology adoption by advanced cold storage devices. This is also going to attract international investors to that region.

Cold Chain Products Market for Plasma Fractionation Trends

To know about the assumptions considered for the study, Request for Free Sample Report

Cold Chain Products Market for Plasma Fractionation

Driver: Rising use of immunoglobulins and other plasma products in a range of therapeutic area

Immunoglobulins (IgG), also known as immune globulin or gamma globulin plays a crucial role in the treatment of primary immunodeficiency and various other conditions. Polyvalent immunoglobulins, prepared from multiple donors, are essential for addressing immunological disorders such as primary and secondary immunodeficiencies. Additionally, high-dose immunoglobulins exhibit immune-modulating effects in neurological, hematological, and dermatological immune diseases. Hyperimmune immunoglobulins with specific antibodies are utilized for preventing or treating infections like tetanus, measles, and rabies, as well as preventing hemolytic diseases in newborns. The demand for plasma fractionation is primarily driven by the clinical utilization of immunoglobulins, which has been steadily increasing and is expected to continue growing. This growing demand for plasma therapeutics, specifically immunoglobulins, in high-income countries can lead to the production of surplus amounts of other therapeutic proteins such as albumin. Consequently, the demand for cold chain products in the plasma fractionation market is projected to rise due to the increased usage of immunoglobulins and other plasma products, requiring storage equipment throughout the manufacturing and application process.

Opportunity: Demand for Plasma Fractionation Centre

The global demand for plasma-derived products is growing at a rate of approximately 7% per year due to increasing prevalence of diseases like hemophilia, immune deficiency disorders, and alpha-I antitrypsin deficiency. The United States, European Union, and China have the highest demand for these products, driven by the high prevalence of such diseases. Other regions, such as India and Africa, also require plasma fractionation centers. India's large population and high disease prevalence contribute to its demand for plasma-derived products, although the country relies on imports due to low plasma collection rates. Similarly, Africa faces limited availability of these products due to low plasma collection rates, often hindered by infrastructure and resource challenges.

Challenge: Shortage of trained manpower & limited resources to maintain the equipment

Plasma freezers and refrigerators play a critical role in storing temperature-sensitive plasma-based therapies. Maintaining the recommended storage temperature is crucial to preserve the quality and effectiveness of these therapies, which have a short shelf life. However, there is a growing concern about the shortage of skilled manpower and limited resources to maintain this vital storage equipment, particularly in developing countries. Insufficient infrastructure and lack of training among healthcare workers contribute to the risk of wastage and compromise patient care. The increased demand for convalescent plasma during the COVID-19 pandemic has further highlighted these challenges. It is imperative for healthcare facilities to prioritize cold chain management, invest in infrastructure, and provide proper training to ensure efficient storage and availability of plasma-based therapies while minimizing wastage.

Cold Chain Products Market for Plasma Fractionation Ecosystem

The ecosystem of the cold chain products industry for plasma fractionation is made up of the components that are present there and specifies these components with a list of the organizations involved. Manufacturers of different cold chain products include the businesses engaged in research, product development, optimization, and introduction of such goods. Distributors include third parties and e-commerce sites affiliated with the organization for selling these cold chain products, whereas end users are the areas where cold chain products are used.

Temperature monitoring devices segment of Cold Chain Products Industry for Plasma Fractionation is expected to witness the fastest growth in the forecast period.

The cold chain products market for plasma fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others. The market category for Temperature monitoring devices is anticipated to grow at the fastest rate between 2022 and 2027. The rising R&D investment on medical devices like medical freezers and refrigerators are additional factors that are expected to boost market expansion throughout the projected period.

Blood collection centers and blood component providers accounted for the largest share of the Cold Chain Products Industry for Plasma Fractionation.

The cold chain products market for plasma fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, The fastest growing market for Cold Chain Products for Plasma Fractionation, was held by Blood collection centers and blood component providers for cold chain products for plasma fractionation. Rising prevalence of diseases like hemophilia, immune deficiency disorders, and liver diseases, increasing aging population are all factors that contribute to the big proportion of this market.

North America accounted for the largest share of the Cold Chain Products Industry for Plasma Fractionation

The cold chain products market for plasma fractionation is divided into five regions based on geography: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the greatest market share for Cold Chain Products for Plasma Fractionation worldwide. It is anticipated that a major driver impacting the North America market growth would be the rising demand for plasma freezers, and the availability of advanced cold storage devices for labs.

The significant market share of North America is related to the presence of good healthcare infrastructure, as well as the rising R&D investment on medical devices like medical freezers and refrigerators.

To know about the assumptions considered for the study, download the pdf brochure

Key players in the Cold Chain Products Market for Plasma Fractionation are B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)

Scope of the Cold Chain Products Industry

The research report categorizes Cold Chain Products Market for Plasma Fractionation to forecast revenue and analyze trends in each of the following submarkets:

By Type

• Ultra-low temperature freezer
• Plasma freezer
• Temperature monitoring devices
• Plasma contact shock freezer
• Blood transport boxes
• Ice-lined refrigerator
• Others

By End User

• Blood collection centers and blood component providers
• Hospitals and transfusion centers
• Clinical research laboratories
• Others

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Australia
  • Japan
  • India
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  • Turkey
  • Rest of MEA

Recent Developments of Cold Chain Products Industry for Plasma Fractionation

• In January 2023, Haier Biomedical (China) acquired Suzhou Kangsheng (China) to incorporate disposable laboratory plastic consumables into its business portfolio and expand smart laboratory application solution scenarios and rapidly expanding its presence into the field of cryopreserving, cell culture, and microbial applications
• In March 2023, Blue Star launched a range of deep freezers with extra storage and higher cooling capacity, manufactured at its new world-class manufacturing facility at Wada.
• In March 2022, B Medical’s Ultra-Low Freezer U201 received the WHO PQS prequalification. This is the first-ever Ultra-Low Freezer in the world to receive the WHO PQS prequalification.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst